There is "insufficient" evidence available to support the introduction a Meningitis B immunisation, Government-appointed experts have said.
The Joint Committee on Vaccination and Immunisation (JCVI) said the efficacy of the Bexsero vaccine "has not been established" and it is "high unlikely" to be cost-effective.
The vaccine was licensed by the European Medicines Agency at the start of the year.
More top news
Defence Secretary James Mattis has distanced himself from Mr Trump's assessment of the media, as has Republican senator John McCain.
A two-year-old boy was found dead in a Perthshire river after being reported missing on Sunday morning.
Eagle-eyed Twitter users spotted that a campaign photo the party claimed was in Stoke on Trent, was actually in Bolton.